Assessment of the stability of 30 antipsychotic drugs in stored blood specimens

Forensic Science International

Volumn 215, Issue 1-3, 2012, Pages 152-158

  Saar, Eva ^a,b   Gerostamoulos, Dimitri ^a,b   Drummer, Olaf H ^a,b   Beyer, Jochen ^a,b  

^a VICTORIAN INSTITUTE OF FORENSIC MEDICINE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Antipsychotic drugs; LC MS MS; Stability; Toxicology; Whole blood

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; BROMPERIDOL; BUSPIRONE; CHLORPROMAZINE; CHLORPROTHIXENE; CLOZAPINE; DROPERIDOL; FLUPHENAZINE; FLUSPIRILENE; HALOPERIDOL; LEVOMEPROMAZINE; MELPERONE; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PERAZINE; PERPHENAZINE; PIMOZIDE; PIPAMPERONE; PROMAZINE; PROMETHAZINE; QUETIAPINE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; TRIFLUOPERAZINE; TRIFLUPROMAZINE; UNINDEXED DRUG; ZIPRASIDONE;

ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG STABILITY; DRUG STORAGE; HUMAN; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; STORAGE TEMPERATURE; STORAGE TIME; TANDEM MASS SPECTROMETRY; TEMPERATURE SENSITIVITY; TIME;

EID: 84856417751     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2011.02.022     Document Type: Article

References (33)

1. Aparasu R.R., Bhatara V., Gupta S. U.S. national trends in the use of antipsychotics during office visits, 1998-2002. Ann. Clin. Psychiatry 2005, 17(3):147-152.
2. Cooper W.O., et al. Trends in prescribing of antipsychotic medications for US children. Ambul. Pediatr. 2006, 6(2):79-83.
3. Baldessarini R.J. Atypical antipsychotic drugs and the risk of sudden cardiac death. N. Engl. J. Med. 2009, 360(20):2136-2137. author reply 2137-8.
4. Ray W.A., et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N. Engl. J. Med. 2009, 360(3):225-235.
5. Ray W.A., et al. Antipsychotics and the risk of sudden cardiac death. Arch. Gen. Psychiatry 2001, 58(12):1161-1167.
6. Lakso H.A. Instability of olanzapine in calf serum. Ther. Drug Monit. 2001, 23(4):454-455.
7. Heller S., et al. Assessment of storage and transport stability of new antidepressant and antipsychotic drugs for a nationwide TDM service. Ther. Drug Monit. 2004, 26(4):459-461.
8. Polla G.I., et al. Thermal behaviour and stability in Olanzapine. Int. J. Pharm. 2005, 301(1-2):33-40.
9. Zhou Z., et al. Simultaneous determination of clozapine, olanzapine, risperidone and quetiapine in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2004, 802(2):257-262.
10. Peters F.T. Stability of analytes in biosamples-an important issue in clinical and forensic toxicology?. Anal. Bioanal. Chem. 2007, 388(7):1505-1519.
11. Gschwend M.H., et al. Selective and sensitive determination of amisulpride in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionisation and multiple reaction monitoring. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2006, 831(1-2):132-139.
12. Chetty M., Miller R. Effect of storage on the plasma concentration of chlorpromazine and six of its metabolites. Ther. Drug Monit. 1991, 13(4):350-355.
13. Swart K.J., et al. Determination of fluspirilene in human plasma by liquid chromatography-tandem mass spectrometry with electrospray ionisation. J. Chromatogr. A 1998, 828(1-2):219-227.
14. Kratzsch C., et al. Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. J. Mass Spectrom. 2003, 38(3):283-295.
15. Holmgren P., et al. Stability of drugs in stored postmortem femoral blood and vitreous humor. J. Forensic Sci. 2004, 49(4):820-825.
16. Hartmann C., et al. Validation of bioanalytical chromatographic methods. J. Pharm. Biomed. Anal. 1998, 17(2):193-218.
17. Dadgar D., Burnett P.E. Issues in evaluation of bioanalytical method selectivity and drug stability. J. Pharm. Biomed. Anal. 1995, 14(1-2):23-31.
18. Dadgar D., et al. Application issues in bioanalytical method validation, sample analysis and data reporting. J. Pharm. Biomed. Anal. 1995, 13(2):89-97.
19. Causon R. Validation of chromatographic methods in biomedical analysis. Viewpoint and discussion. J. Chromatogr. B: Biomed. Sci. Appl. 1997, 689(1):175-180.
20. Nilsson G.H., et al. Influence of pre-analytical conditions on the interpretation of zopiclone concentrations in whole blood. Forensic Sci. Int. 2010, Epub ahead of print.
21. Nilsson G.H., et al. Stability tests of zopiclone in whole blood. Forensic Sci. Int. 2010, 200(1-3):130-135.
22. Saar E., et al. Identification and quantification of 30 antipsychotics in blood using LC-MS/MS. J. Mass Spectrom. 2010, 45(8):915-925.
23. Wieling J., et al. Rational experimental design for bioanalytical methods validation. Illustration using an assay method for total captopril in plasma. J. Chromatogr. A 1996, 730(1-2):381-394.
24. Pounder D.J., Jones G.R. Post-mortem drug redistribution-a toxicological nightmare. Forensic Sci. Int. 1990, 45(3):253-263.
25. Gerostamoulos J., Drummer O.H. Postmortem redistribution of morphine and its metabolites. J. Forensic Sci. 2000, 45(4):843-845.
26. Skopp G. Postmortem toxicology: artifacts. Wiley Encyclopedia of Forensic Science 2009.
27. Haring N., et al. Gas chromatographic-mass spectrometric determination of haloperidol in plasma. Application to pharmacokinetics. Arzneimittelforschung 1987, 37(12):1402-1404.
28. Savello D.R., Shangraw R.F. Stability of sodium ampicillin solutions in the frozen and liquid states. Am. J. Hosp. Pharm. 1971, 28(10):754-759.
29. Bosanquet A.G. Instability of solutions of diaziquone stored at negative temperatures. Int. J. Pharm. 1988, 47:215-222.
30. Davis C.M., Meyer C.J., Fenimore D.C. Improved gas chromatographic analysis of chlorpromazine in blood serum. Clin. Chim. Acta 1977, 78(1):71-77.
31. McKay G., Cooper J.K., Midha K.K. The effect of sample storage on the stability of chlorpromazine in plasma and whole blood. J. Pharmacol. Methods 1984, 12(3):221-223.
32. Dusci L.J., et al. Determination of olanzapine in plasma by high-performance liquid chromatography using ultraviolet absorbance detection. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2002, 773(2):191-197.
33. Bogusz M.J., et al. Monitoring of olanzapine in serum by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J. Chromatogr. B: Biomed. Sci. Appl. 1999, 732(2):257-269.